Web Research
The Bottom Line from the Web
The single most important fact the public record has added to the filings is the SEBI interim ex-parte order of 3 June 2026, which barred Executive Chairman Rajesh Mehta from the securities markets for three years, alleged approximately ₹15.15 lakh crore of revenue overstatement across FY2021–FY2025, alleged a ₹926 crore promoter-diversion through related-party flows and the broker Affluence Shares & Stocks (which has denied any client relationship), and referred statutory auditor BSD & Co. to the NFRA after BDO — the SEBI-appointed forensic auditor — reported being denied ERP access, books of account, and journal dumps. Nothing else in the public record matters as much; every other open question collapses into "does the SEBI order survive 30-day reply, judicial review, and the fresh forensic audit, or does it not?"
Web research data availability — this run. The external research provider returned HTTP 402 (insufficient credit) on all six phase queries (industry, warren, quant, sherlock, historian, forensic) and on all nine specialist-query files. No fresh page text was fetched. The synthesis below is built from (a) the SEBI order facts already captured in the forensic / story / business specialist outputs, (b) the unanswered specialist questions themselves — which become the live research agenda for the next investor work session — and (c) the company's own public filings. Every claim is sourced to internal artifacts; no claim should be read as freshly-corroborated by external press.
SEBI alleged revenue overstatement (₹ crore, FY21–FY25)
SEBI alleged promoter diversion (₹ crore)
Years Rajesh Mehta barred from securities markets
What Matters Most
The ten findings below are ordered by how much each would change an investor's view of the equity today. The first five are existential; the last five reshape the bull / bear range without breaking the thesis.
1. SEBI interim order, 3 June 2026 — the binary node
The order is interim and ex-parte. It directs (i) Rajesh Mehta debarred from securities markets for three years, (ii) fresh forensic audit, (iii) NFRA referral of BSD & Co., (iv) a 30-day reply window for the company. Source: SEBI order — captured in forensics-claude.md and story-claude.md. The next 12–24 months turn on the order's outcome: confirmation → equity value approaches zero / restated equity; vacation / settlement → the 0.17× P/B re-rates sharply.
The order's specific allegations are five: (1) ₹15.15 lakh crore revenue overstatement booked through subsidiary entities REL Singapore, Global Gold Refineries AG (GGR), and Valcambi SA; (2) ₹11,486.60 crore of sales and ₹11,488.42 crore of purchases routed through Affluence Shares & Stocks Private Limited in FY22-FY24, where Affluence has formally denied any client relationship with Rajesh Exports; (3) ₹2,914 crore of long-outstanding receivables adjusted against trade payables without formal agreements; (4) ₹1,035 crore of Africa mining holdings described by SEBI as "unsupported"; (5) statutory auditor BSD & Co. promised audit working papers during depositions and did not produce them.
2. The Valcambi reconciliation that has never been published
The single highest-value missing data point. Audited Valcambi SA standalone revenue for CY2023 was approximately ₹542.68 crore. Audited GGR consolidated revenue for CY2023 was approximately ₹2.92 lakh crore. The consolidated parent (Rajesh Exports) inherits the larger number. No public reconciliation between the two figures exists. SEBI's central allegation rests on this asymmetry. A standalone Valcambi P&L filed in the Swiss commercial register (Kanton Ticino / Moneyhouse / Zefix) would resolve the gross-versus-net dispute in a single document — and it has not been produced.
This is the question Industry, Warren, Quant, Forensic, and Moat all asked independently. It is the highest-priority unanswered item across the entire research plan.
3. The cash balance that disappeared
Cash on the balance sheet fell from approximately ₹14,500 crore at FY2018 to approximately ₹2,053 crore at FY2021, an 86% decline of roughly ₹12,500 crore. There is no commensurate dividend, buyback, declared capex, acquisition, or write-down to absorb the missing balance. The Historian specialist filed this as the largest single unresolved item in the filing set. No external press coverage has explained the decline; management has not addressed it in any subsequent annual report.
4. The ACC battery PLI award — announced loudly, never updated
In FY2022 the company announced selection alongside Reliance Industries and Ola Electric for the ₹18,100 crore Advanced Chemistry Cell (ACC) battery Production-Linked Incentive scheme. FY2023 MDA mentioned it briefly. FY2024 and FY2025 MDA do not mention batteries at all. No plant location update, capex disclosure, production-line status, or PLI milestone has been filed. ACC Energy Storage Pvt Ltd (the named subsidiary in FY25 disclosures) is described as sub-scale with no production. This is either a quietly-abandoned diversification or a still-active business whose progress is undisclosed.
5. The retail dream that hides its store count
The "Shubh Jewellers" retail roll-out has been the stated strategic priority since 2014. The last disclosed store count was approximately 81 stores in FY2018. No store count, same-store-sales-growth figure, retail-segment EBITDA, or expansion milestone has been published since. Phrases such as "aggressively expanding retail footprint" and "dominant retail force" appear verbatim in every annual report from FY2021 through FY2025 — but no quantifiable evidence of expansion exists. Eleven years of stated retail intent without measurable scale converts the retail call-option to zero unless a credible third-party data point (RERA filings, Google Maps listings, footfall studies, GST geo data) emerges.
6. Communication blackout since 2019
The company has not held an earnings call or issued an investor presentation since February 2019. The IR-advisory chain (Valorem → Bridge → Churchgate) was abandoned in the same window. Six years of zero direct investor engagement on a consolidated revenue base that exceeds ₹4 lakh crore is itself a disclosure — and the disclosure is that the company prefers silence to scrutiny. The blackout coincides with the period in which margins compressed, cash collapsed, and the SEBI investigation gestated.
7. The dividend that vanished while net income was still positive
Dividend payouts were suspended from FY2023 onward despite FY2023 reported net income of ₹1,432 crore. A suspension three years before the earnings collapse to ₹95 crore (FY2025) is unusual — it implies the cash need was operating or balance-sheet driven, not driven by earnings deterioration. Combined with finding #3 (cash decline) and finding #8 (promoter pledge question), this is a coherent picture of internal liquidity pressure that the income statement does not yet reflect.
8. Promoter pledge / encumbrance status — not externally confirmed
The 54.55% promoter stake's pledge status has not been independently verified by the public record this run (Parallel API unavailable). The Sherlock specialist filed this as a medium-priority question because pledged promoter shares would be the cleanest explanation for the simultaneous communication blackout, dividend suspension, and refusal to address bad news. A fresh BSE / NSE shareholding pattern filing post-3-June-2026 SEBI order is the next required data point.
9. The independent director who shares the Chairman's surname
Asha Mehta (DIN 08097944) is classified as an Independent Director and chairs the Audit Committee, but shares the surname of Executive Chairman Rajesh Mehta. The familial relationship has not been publicly confirmed or refuted. This is the single largest independence question on the board; the Audit Committee chair's independence is foundational to every accounting representation the board has signed off.
10. Statutory auditor scale mismatch
BSD & Co. (Bangalore-based chartered accountancy firm) is the statutory auditor signing on a consolidated revenue base of approximately ₹7.78 lakh crore (FY2026). The mismatch between a small regional CA firm and a trillion-rupee revenue parent is the textbook breeding-ground condition for a Centerless-Centre style accounting failure. The NFRA referral by SEBI is the first formal external scrutiny of BSD's work; there is no prior NFRA, ICAI, or SEBI action against the firm on the public record.
Recent News Timeline
The timeline below collates publicly-known dated events material to the equity. Items without a confirmed date are flagged. All items are sourced from internal specialist artifacts; the Parallel external search provider returned no fresh page text this run, so the timeline is the union of events already captured by the filings-based specialists.
Coverage gap. The Parallel search provider would normally back-fill (i) post-3-June-2026 BSE/NSE filings, (ii) press / analyst commentary on the SEBI order, (iii) any court filings or appellate motions filed by the company, (iv) shareholder pattern changes, (v) credit-rating actions, (vi) any LBMA disclosure on Valcambi's accreditation status. None of these were fetched this run.
What the Specialists Asked
Eight specialists filed targeted research questions for the web phase. Because the Parallel provider was unavailable, the questions remain open. They are the live research agenda for the next investor session and the single most concrete output of this tab.
Governance and People Signals
Three governance signals dominate the public record. The fourth — promoter pledge — could not be verified externally this run.
Insider transactions, post-3-June-2026. SEBI's order debarred Rajesh Mehta from securities markets for three years. Any subsequent SAST / insider-transaction filing would be a survival-vs-distress signal of the first order. The public-record pull for this run could not be completed; the next research session must start with a fresh BSE/NSE shareholding-pattern read.
Industry Context
The Industry tab carries the structural primer. This section flags only the external evidence required to change the moat or competitive thesis — not a re-statement of the primer.
The external industry signal that would most move the thesis. A disclosed Valcambi standalone treatment-fee schedule (cents-per-ounce by counterparty type — central-bank, miner, bank, refiner) for CY2024 or CY2025, sourced from the Swiss commercial register, would (a) validate the 20-50 cents/oz cited range, (b) anchor the Valcambi standalone earnings power, (c) reduce the consolidated-revenue mystery to a calibration problem rather than a fraud problem. It is the single data point the next research session should pursue first.
Source and Methodology Note
This briefing was assembled without external search data. The Parallel research provider returned HTTP 402 on every query batch attempted for this run — across six phase-level queries and nine specialist query files. All factual claims are sourced from upstream specialist artifacts on disk:
forensics-claude.md— SEBI interim order, Affluence Shares, Africa mining, ₹2,914 crore receivablesstory-claude.md— narrative arc, communication blackout, ACC battery announcementbusiness-claude.md— Valcambi subsidiary structure, REL Singapore, GGRpeople-claude.md— board independence questions, auditor scale mismatchnumbers-claude.md— cash decline, dividend suspension, balance-sheet line itemsmoat-claude.md— LBMA accreditation, competitive positioning- specialist
*-claude-queries.jsonfiles — the open research agenda
A subsequent research session with restored search credit should fire the prioritised questions above in this order: (1) Valcambi standalone financials from Swiss commercial register; (2) SEBI order text and management reply; (3) post-order BSE/NSE shareholding pattern; (4) NFRA action status on BSD & Co.; (5) Affluence Shares broker confirmation; (6) Africa mining valuation; (7) ACC battery plant status; (8) Shubh store count from external sources.